Enteral Nutrition (Oral and Tube Feeding)
Customize your policy alerts
Sign up for sierra health and life Policy MP.027.14 alerts
Get alerted when Policy MP.027.14 changes without checking for updates manually.
Monitor payer policy activity
UnitedHealthcare Commercial and Individual Exchange medical policy addressing medical necessity, coverage limitations, definitions, and applicable codes for enteral nutrition (oral and tube feeding) including Specialized Nutrient Formulas/Medical Foods; applies to UnitedHealthcare Commercial plans and Individual Exchange plans (all states except Wisconsin). This brief covers Part 1 of the policy document.
Supporting Information sections (Description of Services, Clinical Evidence, References) updated to reflect current information; previous policy version archived.
Medical Necessity Criteria for Enteral Nutrition
Enteral Nutrition by Tube Feeding (tube-delivered formulas)
Tube feeding (standard or Specialized Nutrient Formula) is medically necessary in certain circumstances; specific clinical coverage criteria are referenced to InterQual CP for Durable Medical Equipment, Enteral and Parenteral Nutrition Therapy.
ALL of the following
- Enteral nutrition administered by tube feeding (nasogastric, gastrostomy, jejunostomy) is considered medically necessary when criteria in InterQual CP are met
Provider must refer to InterQual® criteria (link provided in policy)
- Standard formula may be considered medically necessary for tube feeding when standard foods cannot be administered through a tube
Operational: tube route justifies standard formula in some cases
Oral Specialized Nutrient Formula (Medical Food) — Medical Necessity
Oral Specialized Nutrient Formula administered orally as primary or supplementary nutrition is medically necessary when ALL of the following are met:
ALL of the following
- Prescribed by a physician, advanced practitioner (NP, CNS, PA), or registered dietitian
- Condition is chronic and expected to last for an undetermined or prolonged period of time
- Adequate nutrition is not possible by dietary adjustment
- The formula used is a Medical Food specially formulated for a specific condition
ONE of the following conditions
- Inborn errors of metabolism (examples: phenylketonuria, maple syrup urine disease, homocystinuria, methylmalonic acidemia, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric aciduria type I, tyrosinemia types I and II, urea cycle disorders)
- Chronic kidney disease stages 2 to 5 (or on dialysis) for individuals aged less than 24 months
- Crohn disease
- Severe malabsorption syndrome (examples: cystic fibrosis, short bowel syndrome, intestinal failure)
- Malnutrition or at risk of malnutrition such that severe outcomes (physical disability, intellectual disability, or death) would occur without nutritional therapy
- Severe food allergies including eosinophilic esophagitis, other eosinophilic gastrointestinal diseases, food protein–induced allergic proctocolitis, and food protein–induced enterocolitis syndrome when left untreated would cause life‑threatening allergic reactions, malnourishment, or death
- Gastroesophageal reflux with failure to thrive (in children)
Oral Nutrition — Not Medically Necessary / Exclusions (summary)
The policy notes exclusions and generally not-covered items for oral intake:
ANY of the following
- Specialized formula when Oral Nutrition criteria are not met
- Standard formula for oral intake
- Self-blenderized formulas for oral intake
- Commercial food thickeners
- Enteral formula additive for oral intake
- Electrolyte-containing fluids for oral intake used to replace fluids and electrolytes
- Formulas for treatment of mild and moderate food allergies or food intolerance
- Oral nutrition for lack of appetite or cognitive conditions (e.g., lack of appetite secondary to stimulant medications)
Clinical indications and guideline-supported uses for amino acid–based formulas and oral nutritional support
Documented indications, guideline recommendations, and clinical scenarios where elemental/amino acid formulas or oral nutritional support are recommended or considered:
ANY of the following
- Eosinophilic esophagitis (EoE) — amino acid–based elemental formulas shown to induce histologic remission (~90.8%) and suggested over no treatment (AGA/JTF conditional recommendation).
Elemental formulas effective especially when extensively hydrolyzed formulas fail or for severe disease.
- Severe food allergies or multiple food eliminations — amino acid formulas considered when symptoms not resolved with extensively hydrolyzed formula, multiple food eliminations needed, or severe eczema/FPIES.
Listed as possible indications in policy supporting evidence.
- Faltering growth/failure to thrive — amino acid formulas considered when growth failure persists despite other interventions.
Referenced in guideline positions (ESPGHAN, CF Foundation)
- Severe malabsorption syndromes including cystic fibrosis with growth deficits — nutritional supplements (oral/enteral) recommended to improve weight gain.
CF Foundation recommendations referenced (pancreatic enzyme dosing guidance also cited).
- Malnutrition or at risk of malnutrition — oral nutrition support or enteral nutrition to be considered per NICE, ASPEN, ESPEN guidance.
Criteria for malnutrition diagnosis per Academy/ASPEN consensus (adult and pediatric indicators) support use of nutritional interventions.
- Gastroesophageal reflux with failure to thrive in infants — 2–4 week trial of extensively hydrolyzed formula or amino acid–based formula suggested after nonpharmacologic measures fail, reserved for severe symptoms.
NASPGHAN/ESPGHAN recommendations.
- Patients at risk of malnutrition prior to discharge (neurologic disease, head/neck cancer, GI malignancy, malabsorptive syndromes) — consider oral nutritional supplements or home enteral nutrition.
ESPEN home enteral nutrition guideline.
Circumstances where amino acid–based formulas are specifically recommended or limited
Guideline nuance regarding when elemental formulas should be used:
ALL of the following
- Elemental/amino acid formulas are highly effective (up to ~90% remission in pediatric EoE) but have drawbacks: high cost, poor palatability, and limited adherence — generally reserved as second-line or for severe disease/multiple allergies.
ESPGHAN position statement and guideline summaries.
HCPCS Codes for Enteral Products and Additives
| B4100 | Food thickener, administered orally, per oz. |
| B4102 | Enteral formula, for adults, used to replace fluids and electrolytes, 500 ml = 1 unit |
| B4103 | Enteral formula, for pediatrics, used to replace fluids and electrolytes, 500 ml = 1 unit |
| B4104 | Additive for enteral formula (e.g., fiber) |
| B4149 | Enteral formula, manufactured blenderized natural foods with intact nutrients, administered through tube, 100 calories = 1 unit |
| B4150 | Enteral formula, nutritionally complete with intact nutrients, administered through tube, 100 calories = 1 unit |
| B4152 | Enteral formula, nutritionally complete, calorically dense (>=1.5 kcal/ml), 100 calories = 1 unit |
| B4153 | Enteral formula, nutritionally complete, hydrolyzed proteins, 100 calories = 1 unit |
| B4154 | Enteral formula, nutritionally complete, for special metabolic needs (excludes inherited disease of metabolism), 100 calories = 1 unit |
| B4155 | Enteral formula, nutritionally incomplete/modular nutrients, 100 calories = 1 unit |
Operational / Documentation and Authorization Requirements
Use InterQual criteria for tube feeding medical necessity
Providers must refer to the InterQual® CP: Durable Medical Equipment, Enteral and Parenteral Nutrition Therapy for the detailed medical necessity clinical coverage criteria supporting tube-fed formulas.
Prescribing requirements for oral Specialized Nutrient Formula
A physician, advanced practitioner (nurse practitioner, certified nurse specialist, or physician assistant), or registered dietitian must prescribe the oral Specialized Nutrient Formula for coverage to be considered.
Risk of denial if oral criteria not met
Coverage for Specialized formula administered orally may be denied if the policy criteria are not fully documented — specifically chronicity of the condition, inability to achieve adequate nutrition by dietary adjustment, that the product is a Medical Food, and presence of a qualifying condition.
Refer to member-specific benefit for exclusions
Check the member-specific benefit plan document to determine whether plan exclusions apply (for example, foods, standard milk-based formulas, donor breast milk, and over-the-counter nutritional supplements).
Document indication and prior treatments tried
Document the clinical indication and prior treatments when requesting elemental or amino acid–based formulas; examples include eosinophilic esophagitis (EoE), multiple food allergies, failure to thrive/faltering growth, and severe malabsorption syndromes. Also document prior use and failure or intolerance of extensively hydrolyzed formulas and objective measures of malnutrition or growth.
- Examples of indications: EoE, multiple food eliminations/food allergies, failure to thrive, cystic fibrosis/short bowel/intestinal failure
- Prior trial and failure/intolerance of extensively hydrolyzed formulas before amino acid–based formulas
- Objective measures: growth metrics, weight trends, laboratory or documented malabsorption
Use guideline-based diagnostic criteria
When malnutrition is the indication, document diagnostic criteria consistent with Academy/ASPEN guidance — at least two recommended adult indicators or appropriate pediatric z-score/weight-loss metrics to support the need for nutritional support.
- Adult: two or more of the six Academy/ASPEN characteristics (e.g., insufficient energy intake; weight loss; loss of muscle mass)
- Pediatric: use z-score thresholds or weight gain/weight loss velocity metrics per the Academy/ASPEN pediatric indicators
Prior authorization may be required (operational)
Obtain any required prior authorization as directed by the member-specific benefit plan and, in authorization requests, reference applicable clinical guidelines (for example, InterQual and professional society guidance); the Instructions for Use direct reviewers to member-specific benefit plans and mandates.
Clinical and Policy Background
Enteral nutrition includes any method of feeding that uses the gastrointestinal tract to deliver nutrition and calories and encompasses a normal oral diet, use of liquid supplements, or delivery by tube feeding (for example, nasogastric, gastrostomy, or jejunostomy) to provide replacement or supplemental nutrition. (See policy Description of Services.)
Specialized Nutrient Formulas, also referred to as Medical Foods, are products that are specially formulated for the dietary management of a disease or condition with distinctive nutritional requirements. These products are designed to be consumed orally or administered enterally and are intended to provide nutritional support that cannot be achieved by modification of the normal diet alone. By regulation and policy definition, Medical Foods are to be used under medical supervision and are intended for patients who require ongoing medical management for their condition.
Specialized Nutrient Formulas (Medical Foods) are intended for individuals whose metabolic, digestive, or disease-related needs cannot be met with standard formulas or ordinary dietary adjustment. They are used when a product with an altered nutrient composition or specific dietary components is required — for example, to manage disturbances in carbohydrate, lipid, vitamin, mineral, amino acid, or nitrogen metabolism — and when standard foods or standard enteral formulas are inadequate to meet the patient’s distinctive nutritional requirements.
Key Definitions
Policy Changes and History
Supporting Information sections (Description of Services, Clinical Evidence, References) updated to reflect current information; previous policy version MP.027.13 archived.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.